Medtech startup Yostra Labs has raised Rs 4 crore in its seed funding round from Indian Angel Network (IAN), Impact Innovators and Entrepreneurs Foundation (Villgro Innovations Foundation), and the Centre for Cellular and Molecular Platforms.
The startup plans to use the funds to hire more sales and marketing talent, as well as to commercialize the product portfolio, optimize bills of materials, and scale up production.
The Bengaluru-based Yostra Labs was founded in 2014 by Vinayak Nandalike and Sanjay Sharma, It builds devices to help patients with chronic diseases better manage their disease.
Its flagship product, NEURO TOUCH—is a comprehensive diagnostic tool for small and large fiber peripheral neuropathy that helps physicians to diagnoses diabetic neuropathy. Other product, Velox Care – an advanced wound care solution for the treatment of chronic wounds such as diabetic foot ulcers
The startup has a portfolio of patented products that focus on diabetic neuropathy that can prevent complications and enhance the livelihoods of diabetics.
The startup is currently addressing-diabetic foot. Its equipment has screened over 40,000 patients in clinics, private and government hospitals and diagnostic centers in India.
“This investment from IAN and co-investors will help Yostra build a business that is sustainable while providing social impact,” said Venkataraman KNK, Lead Investor, IAN.
About Yostra Labs
They are a healthcare technology firm pioneering smart innovations to make healthcare more effective, affordable and sustainable for the cost sensitive developing market.
They are an interdisciplinary team of clinicians, designers and engineers, brought together by the common goal of making a positive impact in affordable healthcare.